SCAN 2019
This autumn the International Neuroendocrine Cancer Alliance INCA invites NET patients and healthcare professionals to scan the access challenges to optimal care for NET patients.
Recent News
Update on Lutathera® announcement by Novartis
Some of you may have seen the announcement, by Novartis, that there is a temporary, voluntary suspension of radioligand therapy production: May 5th 2022 — Novartis today announced a temporary, voluntary suspension of production at its radioligand therapy production...
Carcinoid Heart Disease : The Heart of The Matter
Carcinoid Heart Disease (CHD or Hedinger syndrome), is a rare condition that affects about one in five (20%) patients who have a Neuroendocrine Cancer AND Carcinoid Syndrome (CS). The precise cause is unknown but is thought to be related to abnormally raised levels of...
Fundraiser and Neuroendocrine Cancer patient cycles across Devon raising £6,000
Fundraiser and Neuroendocrine Cancer patient cycles across Devon raising £6,276.20 for NCUK. Well, my bike ride to raise awareness and funds for NCUK felt fantastic - two of the best days of my life! It was nearly a year ago to the day that my consultant told me that...